Papillary thyroid carcinoma with angioinvasion: a literature review
https://doi.org/10.14341/serg13035
Abstract
Papillary thyroid carcinoma (PTC) is the most common form of differentiated thyroid cancer and it is generally characterized by an indolent course. The role of the ability to invade blood vessels and its impact on the prognosis in PTC remain uncertain. The authors conducted an electronic search of publications within the PubMed database. A number of studies demonstrate angioinvasion ceasing to be an independent factor of poor prognosis upon multivariate analysis. The existence of conflicting data on the prognostic role of angioinvasion in PTC may be explained by the difficulty in differentiating between blood vessel and lymphatic vessel invasion, as well as by the use of different criteria for true angioinvasion during morphological examination of surgical specimens. Literature data on the prognostic role of the extent of blood vessel invasion in PTC are limited to a few studies and do not allow for conclusions to be drawn regarding any threshold value for risk of recurrence stratification. When examining tumors of larger size, the dependence of the number of detected invasion foci on the number of examined tumor sections becomes particularly relevant. The issue of the prognostic value of angioinvasion as a risk factor for recurrence and progression of PTC, and as a possible basis for choosing more aggressive treatment tactics, requires further investigation.
About the Authors
A. V. ZolotoukhoRussian Federation
Anna V. Zolotoukho, MD
Researcher ID (WOS): OJT-1407-2025
154 Fontanka River Embankment, 190103 SaintPetersburg
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
A. A. Uspenskaya
Russian Federation
Anna A. Uspenskaya, MD
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
R. A. Chernikov
Russian Federation
Roman A. Chernikov, MD, PhD, Professor
Researcher ID (WOS): AAZ-1549-2021; Scopus Author ID: 57190294900
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
I. V. Sleptsov
Russian Federation
Ilya V. Sleptsov, MD, PhD, Professor
Researcher ID (WOS): F-1670-2019; Scopus Author ID: 57216017997
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
V. P. Govorushkina
Russian Federation
Valeriia P. Govorushkina, MD
Researcher ID: LJK-3276-2024; Scopus Author ID: 57221932437
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
I. M. Feldsherov
Russian Federation
Igor M. Feldsherov, MD
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с содержанием настоящей статьи.
References
1. Falvo L, Catania A, D’Andrea V, et al. Prognostic importance of histologic vascular invasion in papillary thyroid carcinoma. Ann Surg. 2005;241(4):640-646. doi: https://doi.org/10.1097/01.sla.0000157317.60536.08
2. Cao J, Hu JL, Chen C, et al. Vascular invasion is an independent prognostic factor for distant recurrencefree survival in papillary thyroid carcinoma: a matchedcase comparative study. J ClinPathol. 2016;69(10):872-877. doi: https://doi.org/10.1136/jclinpath-2015-203547
3. Nishida T, Katayama Si, Tsujimoto M. The clinicopathological significance of histologic vascular invasion in differentiated thyroid carcinoma. Am J Surg. 2002;183(1):80-86. doi: https://doi.org/10.1016/s0002-9610(01)00843-1
4. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133. doi: https://doi.org/10.1089/thy.2015.0020
5. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214. doi: https://doi.org/10.1089/thy.2009.0110
6. Ringel MD, Sosa JA, Baloch Z, et al. 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid. 2025;35(8):841-985. doi: https://doi.org/10.1177/10507256251363120
7. Leong D, GillAJ, TurchiniJ, etal. The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma. World J Surg. 2023;47(2):412-420. doi: https://doi.org/10.1007/s00268-022-06696-6
8. Xu B, Roy D, Serrette R, Ghossein R. Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40/CD31/ERG immunohistochemistry and correlation with clinicopathological characteristics. Histopathology. 2024;85(6):950-958. doi: https://doi.org/10.1111/his.15285
9. Mai KT, Khanna P, Yazdi HM, et al. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Pathology. 2002;34(3):239-244. doi: https://doi.org/10.1080/00313020220131291
10. Wreesmann VB, Nixon IJ, Rivera M, et al. Prognostic value of vascular invasion in well-differentiated papillary thyroid carcinoma. Thyroid. 2015;25(5):503-508. doi: https://doi.org/10.1089/thy.2015.0052
11. Furlan JC, Bedard YC, Rosen IB. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg. 2004;198(3):341-348. doi: https://doi.org/10.1016/j.jamcollsurg.2003.11.012
12. Lang BH, Shek TW, Wan KY. The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1-4 cm: implications for completion thyroidectomy following lobectomy. Clin Endocrinol (Oxf ). 2017;86(2):236-242. doi: https://doi.org/10.1111/cen.13165
13. Wagner K, Abraham E, Tran B, et al. Lymphovascular invasion and risk of recurrence in papillary thyroid carcinoma. ANZ J Surg. 2020;90(9):1727-1732. doi: https://doi.org/10.1111/ans.16202
14. Puga FM, Al Ghuzlan A, Hartl DM, et al. Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational study. Endocrine. 2024;83(1):150-159. doi: https://doi.org/10.1007/s12020-023-03475-8
15. Vuong HG, Kondo T, Duong UNP, et al. Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis. Eur J Endocrinol. 2017;177(2):207-216. doi: https://doi.org/10.1530/EJE-17-0260
16. Vuong HG, Duong UNP, Pham TQ, et al. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis. World J Surg. 2018;42(4):1005-1017. doi: https://doi.org/10.1007/s00268-017-4206-1
17. Barletta J, Fadda G, Kakudo K, et al. Follicular thyroid carcinoma. In: WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Endocrine and Neuroendocrine Tumours. 5th ed, vol. 10. International Agency for Research on Cancer; 2022. Updated October 4, 2023. Accessed [April 20, 2025]. https://tumourclassification.iarc.who.int/chapters/53
18. LiVolsi V, Mete O, Baloch ZW, et al. Oncocytic carcinoma of the thyroid. In: WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Endocrine and Neuroendocrine Tumours. 5th ed, vol. 10. International Agency for Research on Cancer; 2022. Updated October 4, 2023. Accessed [April 20, 2025]. https://tumourclassification.iarc.who.int/chapters/53
19. Ragazzi M, Besutti G, Mancuso P, et al. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study. Histopathology. 2024;85(1):62-74. doi: https://doi.org/10.1111/his.15173
20. Xu B, Wang L, Tuttle RM, et al. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. Hum Pathol. 2015;46(12):1789-1798. doi: https://doi.org/10.1016/j.humpath.2015.08.015
21. Mete O, Asa SL. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol. 2011;24(12):1545-1552. doi: https://doi.org/10.1038/modpathol.2011.119
22. Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative Stress in Cancer. Cancer Cell. 2020;38(2):167-197. doi: https://doi.org/10.1016/j.ccell.2020.06.001
23. Kościuszko M, Buczyńska A, Krętowski AJ, Popławska-Kita A. Could Oxidative Stress Play a Role in the Development and Clinical Management of Differentiated Thyroid Cancer?.Cancers (Basel). 2023;15(12):3182. doi: https://doi.org/10.3390/cancers15123182
24. Ameziane El Hassani R, Buffet C, Leboulleux S, Dupuy C. Oxidative stress in thyroid carcinomas: biological and clinical significance. EndocrRelat Cancer. 2019;26(3):R131-R143. doi: https://doi.org/10.1530/ERC-18-0476
25. Xing M. Oxidative stress: a new risk factor for thyroid cancer. EndocrRelat Cancer. 2012;19(1):C7-C11. doi: https://doi.org/10.1530/ERC-11-0360
26. Muzza M, Pogliaghi G, Colombo C, et al. Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer. Cancers (Basel). 2022;14(23):5857. doi: https://doi.org/10.3390/cancers14235857
27. Buczyńska A, Sidorkiewicz I, Rogucki M, et al. Oxidative stress and radioiodine treatment of differentiated thyroid cancer. Sci Rep. 2021;11(1):17126. doi: https://doi.org/10.1038/s41598-021-96637-5
28. Buczyńska A, Sidorkiewicz I, Kościuszko M, et al. Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer. Sci Rep. 2023;13(1):13711. doi: https://doi.org/10.1038/s41598-023-40898-9
29. Buczyńska, A., Kościuszko, M., Sidorkiewicz, I et al. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin. J Clin Endocrinol Metab. 2024;109(7),1866–1872. doi: https://doi.org/10.1210/clinem/dgae007
30. Rogucki M, Buczyńska A, Krętowski AJ, Popławska-Kita A. The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer. Journal of Clinical Medicine. 2021; 10(20):4738. doi: https://doi.org/10.3390/jcm10204738
31. Acibucu F, Dökmetaş HS, Tutar Y et al. Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers. ExpClin Endocrinol Diabetes. 2014;122(3):137-143. doi: https://doi.org/10.1055/s-0034-1367025
32. Buczyńska A, Kościuszko M, Krętowski AJ, Popławska-Kita A. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review. Front Endocrinol (Lausanne). 2023;14:1261860. doi: https://doi.org/10.3389/fendo.2023.1261860
Review
For citations:
Zolotoukho A.V., Uspenskaya A.A., Chernikov R.A., Sleptsov I.V., Govorushkina V.P., Feldsherov I.M. Papillary thyroid carcinoma with angioinvasion: a literature review. Endocrine Surgery. 2025;19(4):22-27. (In Russ.) https://doi.org/10.14341/serg13035
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).



































